HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stephen Gottschalk Selected Research

Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)

1/2022Infectious Complications in Pediatric, Adolescent and Young Adult Patients Undergoing CD19-CAR T Cell Therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stephen Gottschalk Research Topics

Disease

99Neoplasms (Cancer)
05/2024 - 01/2002
16Hematologic Neoplasms (Hematological Malignancy)
02/2024 - 04/2011
14Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
02/2024 - 01/2016
14Glioma (Gliomas)
12/2023 - 03/2011
13Glioblastoma (Glioblastoma Multiforme)
12/2023 - 03/2013
13Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2023 - 11/2008
10Infections
11/2023 - 09/2011
8Brain Neoplasms (Brain Tumor)
05/2024 - 03/2011
8Hodgkin Disease (Hodgkin's Disease)
01/2022 - 01/2002
8Lymphoma (Lymphomas)
11/2018 - 05/2006
7Leukemia
12/2023 - 09/2011
6Osteosarcoma (Osteogenic Sarcoma)
01/2021 - 10/2009
5Sarcoma (Soft Tissue Sarcoma)
04/2024 - 01/2015
5Virus Diseases (Viral Diseases)
11/2021 - 09/2011
5Nasopharyngeal Carcinoma
01/2019 - 07/2007
4Bites and Stings (Sting)
01/2021 - 01/2016
4Hepatocellular Carcinoma (Hepatoma)
01/2021 - 03/2013
4Lymphoproliferative Disorders (Lymphoproliferative Disorder)
11/2018 - 01/2005
3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
12/2022 - 01/2022
3Breast Neoplasms (Breast Cancer)
11/2021 - 06/2007
3Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2019 - 03/2014
2Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
03/2024 - 01/2015
2B-Cell Lymphoma (Lymphoma, B Cell)
01/2023 - 01/2020
2Communicable Diseases (Infectious Diseases)
01/2022 - 05/2009
2Lymphopenia (Lymphocytopenia)
01/2022 - 03/2009
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2021 - 01/2021
2Human Influenza (Influenza)
01/2020 - 08/2012
2Head and Neck Neoplasms (Head and Neck Cancer)
11/2017 - 08/2011
2Graft vs Host Disease (Graft-Versus-Host Disease)
11/2008 - 12/2006
1Fibrosis (Cirrhosis)
05/2024
1Sickle Cell Anemia (Hemoglobin S Disease)
05/2024
1Viremia
03/2024
1Carcinoma (Carcinomatosis)
03/2024
1Residual Neoplasm
12/2023
1Starvation
11/2023
1Central Nervous System Neoplasms
11/2023
1Infertility (Sterility)
11/2023
1Encephalitis (Encephalitis, Rasmussen)
11/2023
1Cytokine Release Syndrome
10/2023
1Cytopenia
01/2023
1Neuroblastoma
01/2022
1Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
01/2022
1Neoplasm Metastasis (Metastasis)
01/2021

Drug/Important Bio-Agent (IBA)

63Chimeric Antigen ReceptorsIBA
05/2024 - 06/2007
56AntigensIBA
05/2024 - 03/2003
16CytokinesIBA
12/2023 - 01/2002
10Proteins (Proteins, Gene)FDA Link
05/2024 - 03/2003
9Neoplasm Antigens (Tumor Antigens)IBA
01/2022 - 01/2002
8Membrane Proteins (Integral Membrane Proteins)IBA
01/2019 - 05/2006
5CD19-specific chimeric antigen receptorIBA
03/2024 - 01/2022
5Monoclonal AntibodiesIBA
12/2023 - 03/2005
5human ERBB2 proteinIBA
05/2015 - 06/2007
5VaccinesIBA
08/2013 - 02/2007
4RNA (Ribonucleic Acid)IBA
05/2024 - 06/2011
4AntibodiesIBA
12/2023 - 03/2011
4ErythropoietinFDA Link
01/2021 - 03/2013
4Antiviral Agents (Antivirals)IBA
10/2019 - 09/2011
4EpitopesIBA
01/2019 - 05/2006
4Interleukin-2 (IL2)IBA
09/2017 - 06/2007
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2024 - 04/2021
3T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2022 - 01/2022
3InterleukinsIBA
01/2020 - 03/2013
3Viral AntigensIBA
01/2015 - 10/2007
2Protein Isoforms (Isoforms)IBA
05/2024 - 01/2024
2Fibronectins (Fibronectin)IBA
05/2024 - 01/2021
2fludarabineIBA
04/2024 - 01/2022
2Endoplasmic Reticulum Chaperone BiPIBA
02/2024 - 01/2022
2Biomarkers (Surrogate Marker)IBA
10/2023 - 01/2019
2Interleukin-15 (Interleukin 15)IBA
01/2023 - 03/2009
2tisagenlecleucelIBA
01/2022 - 01/2022
2Peptides (Polypeptides)IBA
01/2022 - 01/2018
2SurvivinIBA
01/2022 - 01/2022
2Immunoconjugates (Immunoconjugate)IBA
01/2022 - 08/2013
2LigandsIBA
11/2021 - 03/2005
2Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2018 - 12/2017
2Bispecific AntibodiesIBA
01/2018 - 04/2015
2InterferonsIBA
09/2017 - 03/2013
1Cell Surface ReceptorsIBA
12/2023
1CholesterolIBA
12/2023
1Interleukin-10 ReceptorsIBA
11/2023
1Cytokine Receptors (Cytokine Receptor)IBA
11/2023
1EndotoxinsIBA
11/2023
1CD19 AntigensIBA
01/2023
1Antigen Receptors (Antigen Receptor)IBA
01/2023
1HLA-A Antigens (HLA-A)IBA
01/2022
1DNA Methyltransferase 3AIBA
11/2021
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
11/2021
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2021
1Mucin-1 (CA 15-3 Antigen)IBA
11/2021

Therapy/Procedure

55Therapeutics
03/2024 - 01/2002
47Immunotherapy
05/2024 - 03/2005
11Hematopoietic Stem Cell Transplantation
01/2021 - 01/2002
9Drug Therapy (Chemotherapy)
12/2023 - 07/2007
8Cell- and Tissue-Based Therapy (Cell Therapy)
03/2024 - 08/2011
5Cell Transplantation
05/2024 - 01/2020
5Bone Marrow Transplantation (Transplantation, Bone Marrow)
03/2024 - 05/2006
4Transplantation
02/2024 - 11/2008
3Stem Cell Transplantation
04/2013 - 12/2006
1Surgical Amputation (Amputations)
01/2021
1Combined Modality Therapy
01/2021